ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,509.01
0.62%
US Tech 100
19,468.40
-0.06%
Dow Jones
39,331.85
0.00%
Brent Oil
86.24
-0.24%
Bitcoin
60,131.03
-3.06%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Revolution Medicines Inc (RVMD)

  7. Revolution Medicines Inc (RVMD) News

RVMD

Revolution Medicines (RVMD)

Revolution Medicines Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:RVMD
DateTimeSourceHeadlineSymbolCompany
11/14/20238:13PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RVMDRevolution Medicines Inc
11/14/20238:13PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:RVMDRevolution Medicines Inc
11/09/20239:20AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RVMDRevolution Medicines Inc
11/09/20239:10AMGlobeNewswire Inc.Revolution Medicines Completes Acquisition of EQRxNASDAQ:RVMDRevolution Medicines Inc
11/08/202311:30AMGlobeNewswire Inc.Revolution Medicines and EQRx Stockholders Approve EQRx AcquisitionNASDAQ:RVMDRevolution Medicines Inc
11/06/20234:09PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RVMDRevolution Medicines Inc
11/06/20234:05PMGlobeNewswire Inc.Revolution Medicines Reports Third Quarter 2023 Financial Results and Update on Corporate ProgressNASDAQ:RVMDRevolution Medicines Inc
11/06/20234:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RVMDRevolution Medicines Inc
11/01/20237:15AMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:RVMDRevolution Medicines Inc
11/01/20237:11AMEdgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:RVMDRevolution Medicines Inc
11/01/20237:08AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RVMDRevolution Medicines Inc
11/01/20237:00AMGlobeNewswire Inc.Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Revolution Medicines Stockholders Vote “FOR” Proposed Acquisition of EQRx, Inc.NASDAQ:RVMDRevolution Medicines Inc
10/31/20234:15PMGlobeNewswire Inc.Revolution Medicines to Report Financial Results for Third Quarter 2023 After Market Close on November 6, 2023NASDAQ:RVMDRevolution Medicines Inc
10/23/20236:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RVMDRevolution Medicines Inc
10/23/20236:13AMEdgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:RVMDRevolution Medicines Inc
10/23/20236:13AMEdgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:RVMDRevolution Medicines Inc
10/23/20236:11AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RVMDRevolution Medicines Inc
10/22/20232:30AMGlobeNewswire Inc.Revolution Medicines Presents Promising Clinical Activity and Safety Data from Phase 1/1b Trial of RMC-6236NASDAQ:RVMDRevolution Medicines Inc
10/13/202311:54AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RVMDRevolution Medicines Inc
10/13/202311:50AMGlobeNewswire Inc.Revolution Medicines Presents Encouraging Clinical Data for RMC-6236 and RMC-6291 at 2023 Triple MeetingNASDAQ:RVMDRevolution Medicines Inc
10/04/20234:05PMGlobeNewswire Inc.Revolution Medicines to Present New Clinical Data at Major Oncology Conferences and Host Investor WebcastNASDAQ:RVMDRevolution Medicines Inc
10/02/20234:12PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RVMDRevolution Medicines Inc
09/29/20234:19PMEdgar (US Regulatory)Form DEFM14A - Definitive proxy statement relating to merger or acquisitionNASDAQ:RVMDRevolution Medicines Inc
09/29/20234:17PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:RVMDRevolution Medicines Inc
09/28/20234:10PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RVMDRevolution Medicines Inc
09/27/20235:25PMEdgar (US Regulatory)Form S-4/A - Registration of securities, business combinations: [Amend]NASDAQ:RVMDRevolution Medicines Inc
09/20/20234:11PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RVMDRevolution Medicines Inc
09/20/20234:11PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RVMDRevolution Medicines Inc
09/19/20239:41PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RVMDRevolution Medicines Inc
09/19/20239:12PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RVMDRevolution Medicines Inc
 Showing the most relevant articles for your search:NASDAQ:RVMD

Your Recent History

NASDAQ
TSLA
Tesla
USOTC
NNAX
New Momentum (PK)
USOTC
AABB
Asia Broadband (PK)
USOTC
RSPI
RespireRx Pharmaceuticals (PK)
USOTC
CNNA
Cann American (CE)
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
RNVA
Rennova Health (PK)
USOTC
TSOI
Therapeutic Solutions (PK)
USOTC
HMBL
HUMBL (PK)
USOTC
AXXA
Exxe (PK)
USOTC
CATV
4Cable TV (PK)
USOTC
PHIL
PHI (PK)
USOTC
BLLB
Bell Buckle (PK)
USOTC
GGSM
Gold and GemStone Mining (PK)
USOTC
SMCE
SMC Entertainment (PK)
USOTC
WDLF
Decentral Life (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved